Product Name

  • Name

    Everolimus

  • EINECS 621-003-9
  • CAS No. 159351-69-6
  • Article Data20
  • CAS DataBase
  • Density 1.18 g/cm3
  • Solubility Soluble in dimethysulfoxide,ethanol and chloroform. Slightly soluble in water.
  • Melting Point NA
  • Formula C53H83NO14
  • Boiling Point 998.7 °C at 760 mmHg
  • Molecular Weight 958.24
  • Flash Point 557.8 °C
  • Transport Information
  • Appearance off white solid
  • Safety 45
  • Risk Codes 48/25
  • Molecular Structure Molecular Structure of 159351-69-6 (Everolimus)
  • Hazard Symbols ToxicT
  • Synonyms 40-O-(2-Hydroxyethyl)rapamycin;42-O-(2-Hydroxy)ethylrapamycin;Certican;RAD;RAD 001;SDZ-RAD;XIENCE V;
  • PSA 204.66000
  • LogP 6.13510

Synthetic route

42-O-trityl-everolimus

42-O-trityl-everolimus

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In methanol; water Solvent; Reagent/catalyst;88%
With 1,1,1,3',3',3'-hexafluoro-propanol at 58℃; for 3.5h;
28-O-TES-42-O-THDMS everolimus

28-O-TES-42-O-THDMS everolimus

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With sulfuric acid In tetrahydrofuran at 0 - 10℃; for 1h;71%
With sulfuric acid In tetrahydrofuran at 0 - 10℃; for 1h; Reagent/catalyst;3.72 g
28-O-TMS-42-O-TBS everolimus

28-O-TMS-42-O-TBS everolimus

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In water; acetone at 0 - 5℃; for 1h;68.3%
With hydrogenchloride In water; acetonitrile at -10 - 0℃; for 0.5h;20.4 g
With hydrogenchloride In acetone at 0 - 5℃; for 1h;3.58 g
42-O-[2-(1-methyl-1-methoxyethoxy)ethyl]rapamycin

42-O-[2-(1-methyl-1-methoxyethoxy)ethyl]rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 5℃; pH=3 - 4;68%
42-O-[2(tetrahydrofuran-2-oxy)ethyl]rapamycin

42-O-[2(tetrahydrofuran-2-oxy)ethyl]rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 5℃;67%
42-O-[2-(1-ethoxyethoxy)ethyl]rapamycin

42-O-[2-(1-ethoxyethoxy)ethyl]rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 5℃;65%
42-O-[2(tetrahydro-2H-furan-2-oxy)ethyl]rapamycin

42-O-[2(tetrahydro-2H-furan-2-oxy)ethyl]rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 5℃;61%
42-O-[2-(methoxymethoxy)ethyl]rapamycin

42-O-[2-(methoxymethoxy)ethyl]rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 5℃;55%
40-O-[2-(t-butyldimethylsilyl)oxy]ethyl rapamycin
159351-68-5

40-O-[2-(t-butyldimethylsilyl)oxy]ethyl rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With triethylamine tris(hydrogen fluoride) In tetrahydrofuran at 20℃; for 2h;54%
With pyridine hydrogenfluoride In tetrahydrofuran at 0 - 45℃; for 1.5h;2.96 g
With hydrogenchloride In methanol; water at 0 - 25℃; for 1h; pH=1-3; pH-value; Time;
40-O-[2-(t-butyldiphenylsilyl)oxy]ethyl-rapamycin
1314705-20-8

40-O-[2-(t-butyldiphenylsilyl)oxy]ethyl-rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With pyridine; hydrogen fluoride In tetrahydrofuran at 0 - 20℃; for 4h;15%
With pyridine hydrogenfluoride In tetrahydrofuran at 0 - 20℃; for 4h;15%
With pyridine hydrogenfluoride In tetrahydrofuran at 0 - 45℃; for 3.5h; Temperature;6.81 g
With hydrogenchloride In water; acetonitrile at -10 - 0℃; for 0.5h;
40-O-[2-((2,3-dimethylbut-2-yl)dimethylsilyloxy)ethyl] rapamycin
1392400-31-5

40-O-[2-((2,3-dimethylbut-2-yl)dimethylsilyloxy)ethyl] rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 0℃; for 1.5h;
With hydrogenchloride In methanol; water at -10℃; Inert atmosphere;
C74H101NO16

C74H101NO16

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With 1,1,1,3',3',3'-hexafluoro-propanol at 50℃; for 1.5h; Reagent/catalyst;621 mg
sirolimus
53123-88-9

sirolimus

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (1-ethylpropyl)diisopropylamine / toluene / 30 °C
2: pyridine hydrogenfluoride / tetrahydrofuran / 3.5 h / 0 - 45 °C
View Scheme
Multi-step reaction with 2 steps
1.1: 2,6-dimethylpyridine; trifluoromethylsulfonic anhydride / dichloromethane / 0.5 h / -40 °C
1.2: -40 - 40 °C
2.1: hydrogenchloride / methanol; water / 1 h / 0 - 25 °C / pH 1-3
View Scheme
Multi-step reaction with 2 steps
1: N-ethyl-N,N-diisopropylamine / toluene / 12 h / 60 °C
2: hydrogenchloride / methanol; water / 5 °C
View Scheme
40-O-[2-(triisopropylsilyl)oxy]ethyl-rapamycin

40-O-[2-(triisopropylsilyl)oxy]ethyl-rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride; phosphoric acid; water In n-heptane; acetonitrile at 20℃; for 24h;64 %Chromat.
31,42-bis(trimethylsilylether)rapamycin
331810-13-0

31,42-bis(trimethylsilylether)rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / tetrahydrofuran / 5 h / Cooling with ice
2: hydrogenchloride / toluene; water / 6 h / 0 - 10 °C
3: hydrogenchloride / water; methanol / 4.5 h / Cooling with ice
View Scheme
Multi-step reaction with 3 steps
1: hydrogenchloride / ethyl acetate; water / Cooling with ice
2: N-ethyl-N,N-diisopropylamine / 1,2-dimethoxyethane; toluene / 4 h / 60 °C
3: hydrogenchloride / water; acetone / 1 h / 0 - 5 °C
View Scheme
Multi-step reaction with 3 steps
1: hydrogenchloride / water / Cooling with ice
2: N-ethyl-N,N-diisopropylamine / toluene; 1,2-dimethoxyethane / 4 h / 60 °C
3: hydrogenchloride / acetone / 1 h / 0 - 5 °C
View Scheme
C56H91NO14Si

C56H91NO14Si

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In methanol; water for 4.5h; Cooling with ice;3.8 g
oxirane
75-21-8

oxirane

sirolimus
53123-88-9

sirolimus

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With trifluorormethanesulfonic acid In toluene at 70℃; under 7500.75 Torr; for 8h; Reagent/catalyst; Temperature; Pressure; Solvent; Autoclave;6.9 g
ethylene glycol
107-21-1

ethylene glycol

sirolimus
53123-88-9

sirolimus

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
Stage #1: ethylene glycol With trifluoroacetic anhydride In tetrahydrofuran at 10℃; for 1.5h; Inert atmosphere; Large scale;
Stage #2: sirolimus With boron trifluoride diethyl etherate In tetrahydrofuran at 10℃; for 2h; Temperature; Large scale;
5.7 kg
C56H91NO14Si

C56H91NO14Si

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In water; acetonitrile at -10 - 0℃; for 0.5h;
C59H97NO14Si

C59H97NO14Si

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
With hydrogenchloride In water; acetonitrile at -10 - 0℃; for 0.5h;
31-(trimethylsilylether)rapamycin
331810-10-7

31-(trimethylsilylether)rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: N-ethyl-N,N-diisopropylamine / 1,2-dimethoxyethane; toluene / 4 h / 60 °C
2: hydrogenchloride / water; acetone / 1 h / 0 - 5 °C
View Scheme
Multi-step reaction with 2 steps
1: N-ethyl-N,N-diisopropylamine / toluene; 1,2-dimethoxyethane / 4 h / 60 °C
2: hydrogenchloride / acetone / 1 h / 0 - 5 °C
View Scheme
31,42-bis(triethylsilylether)rapamycin
155435-45-3

31,42-bis(triethylsilylether)rapamycin

everolimus
159351-69-6

everolimus

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sulfuric acid / acetone / 0 - 10 °C
2: N-ethyl-N,N-diisopropylamine / toluene / 4 h / 53 °C
3: sulfuric acid / tetrahydrofuran / 1 h / 0 - 10 °C
View Scheme
Multi-step reaction with 3 steps
1: sulfuric acid / acetone / 0 - 10 °C
2: N-ethyl-N,N-diisopropylamine / toluene; hexane / 2 h / 60 °C
3: sulfuric acid / tetrahydrofuran / 1 h / 0 - 10 °C
View Scheme
vinyl bromoacetate
5309-70-6

vinyl bromoacetate

everolimus
159351-69-6

everolimus

everolimus 42-bromoacetate
159351-81-2

everolimus 42-bromoacetate

Conditions
ConditionsYield
Novozym 435TM lipase In tert-butyl methyl ether at 35℃; for 10h; Molecular sieve;96%
at 20℃; for 4h; Enzymatic reaction;
everolimus
159351-69-6

everolimus

42-O-(2-fluoroethyl)rapamycin
1422173-29-2

42-O-(2-fluoroethyl)rapamycin

Conditions
ConditionsYield
With 1,3-bis(2,6-diisopropylphenyl)-2,2-difluoro-2,3-dihydro-1h-imidazole; N-ethyl-N,N-diisopropylamine In dichloromethane at 23℃; for 5h; Inert atmosphere;83%
Iodoacetic acid
64-69-7

Iodoacetic acid

everolimus
159351-69-6

everolimus

SDZ-RAD-iodoacetate ester

SDZ-RAD-iodoacetate ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; Inert atmosphere; Darkness;73%
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2.66667h;
2-{[tert-butyl(diphenyl)silyl]oxy}ethyl trifluoromethansulphonate

2-{[tert-butyl(diphenyl)silyl]oxy}ethyl trifluoromethansulphonate

everolimus
159351-69-6

everolimus

(35E,37E,39E,40E,48R,49S,50R,51R,53S,55S,57S,58S,59R,60R,69R)-58-[(1R)-2-[(1S,3R,4R)-4-[2-[2-[tert-butyl(diphenyl)silyl]oxyethoxy]ethoxy]-3-methoxy-cyclohexyl]-1-methyl-ethyl]-59,69-dihydroxy-57,60-dimethoxy-48,49,50,51,61,62-hexamethyl-79,80-dioxa-71-azatricyclohexatriaconta-35,37,39(61),40(62)-tetraene-63,64,65,66,67-pentone

(35E,37E,39E,40E,48R,49S,50R,51R,53S,55S,57S,58S,59R,60R,69R)-58-[(1R)-2-[(1S,3R,4R)-4-[2-[2-[tert-butyl(diphenyl)silyl]oxyethoxy]ethoxy]-3-methoxy-cyclohexyl]-1-methyl-ethyl]-59,69-dihydroxy-57,60-dimethoxy-48,49,50,51,61,62-hexamethyl-79,80-dioxa-71-azatricyclohexatriaconta-35,37,39(61),40(62)-tetraene-63,64,65,66,67-pentone

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In toluene at 45℃; for 18h;59%
everolimus
159351-69-6

everolimus

C53H83NO14

C53H83NO14

Conditions
ConditionsYield
With zinc(II) chloride In tetrahydrofuran at 60℃; for 2h; Reagent/catalyst;45%
everolimus
159351-69-6

everolimus

(22E,24E,26E,27E,31R,32S,33R,34R,36S,38S,40S,41S,42S,43R,52R)-42,52-dihydroxy-41-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-40,43-dimethoxy-31,32,33,34,44,45-hexamethyl-62,63-dioxa-53-azatricyclohexatriaconta-22,24,26(44),27(45)-tetraene-46,47,48,49,50-pentone

(22E,24E,26E,27E,31R,32S,33R,34R,36S,38S,40S,41S,42S,43R,52R)-42,52-dihydroxy-41-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-40,43-dimethoxy-31,32,33,34,44,45-hexamethyl-62,63-dioxa-53-azatricyclohexatriaconta-22,24,26(44),27(45)-tetraene-46,47,48,49,50-pentone

Conditions
ConditionsYield
With titanium(IV) isopropylate In dichloromethane at 20℃;38%
everolimus
159351-69-6

everolimus

2,2'-[1,2-ethanediylbis(oxy)]bisethanol
112-27-6

2,2'-[1,2-ethanediylbis(oxy)]bisethanol

(21E,23E,25E,26E,36R,37S,38R,39R,41S,43S,46S,47R,48R,57R)-47,57-dihydroxy-45-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]-46-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-48-methoxy-36,37,38,39,49,50-hexamethyl-68,69-dioxa-58-azatricyclohexatriaconta-21,23,25(49),26(50)-tetraene-51,52,53,54,55-pentone

(21E,23E,25E,26E,36R,37S,38R,39R,41S,43S,46S,47R,48R,57R)-47,57-dihydroxy-45-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]-46-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-48-methoxy-36,37,38,39,49,50-hexamethyl-68,69-dioxa-58-azatricyclohexatriaconta-21,23,25(49),26(50)-tetraene-51,52,53,54,55-pentone

Conditions
ConditionsYield
With toluene-4-sulfonic acid In tetrahydrofuran; water at 20℃; for 2h;28%
everolimus
159351-69-6

everolimus

diethylene glycol
111-46-6

diethylene glycol

(21E,23E,25E,26E,34R,35S,36R,37R,39S,41S,44S,45R,46R,55R)-45,55-dihydroxy-43-[2-(2-hydroxyethoxy)ethoxy]-44-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-46-methoxy-34,35,36,37,47,48-hexamethyl-66,67-dioxa-56-azatricyclohexatriaconta-21,23,25(47),26(48)-tetraene-49,50,51,52,53-pentone

(21E,23E,25E,26E,34R,35S,36R,37R,39S,41S,44S,45R,46R,55R)-45,55-dihydroxy-43-[2-(2-hydroxyethoxy)ethoxy]-44-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-46-methoxy-34,35,36,37,47,48-hexamethyl-66,67-dioxa-56-azatricyclohexatriaconta-21,23,25(47),26(48)-tetraene-49,50,51,52,53-pentone

Conditions
ConditionsYield
With toluene-4-sulfonic acid In tetrahydrofuran; water at 20℃; for 2h;19%
Tetraethylene glycol
112-60-7

Tetraethylene glycol

everolimus
159351-69-6

everolimus

(21E,23E,25E,26E,38R,39S,40R,41R,43S,45S,48S,49R,50R,59R)-49,59-dihydroxy-47-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]-48-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-50-methoxy-38,39,40,41,51,52-hexamethyl-70,71-dioxa-60-azatricyclohexatriaconta-21,23,25(51),26(52)-tetraene-53,54,55,56,57-pentone

(21E,23E,25E,26E,38R,39S,40R,41R,43S,45S,48S,49R,50R,59R)-49,59-dihydroxy-47-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]-48-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-50-methoxy-38,39,40,41,51,52-hexamethyl-70,71-dioxa-60-azatricyclohexatriaconta-21,23,25(51),26(52)-tetraene-53,54,55,56,57-pentone

Conditions
ConditionsYield
With toluene-4-sulfonic acid In tetrahydrofuran; water at 20℃; for 2h;17%
heptaethylene glycol
5617-32-3

heptaethylene glycol

everolimus
159351-69-6

everolimus

(21E,23E,25E,26E,44R,45S,46R,47R,49S,51S,54S,55R,56R,65R)-55,65-dihydroxy-53-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-54-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-56-methoxy-44,45,46,47,57,58-hexamethyl-76,77-dioxa-66-azatricyclohexatriaconta-21,23,25(57),26(58)-tetraene-59,60,61,62,63-pentone

(21E,23E,25E,26E,44R,45S,46R,47R,49S,51S,54S,55R,56R,65R)-55,65-dihydroxy-53-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-54-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-56-methoxy-44,45,46,47,57,58-hexamethyl-76,77-dioxa-66-azatricyclohexatriaconta-21,23,25(57),26(58)-tetraene-59,60,61,62,63-pentone

Conditions
ConditionsYield
With toluene-4-sulfonic acid In tetrahydrofuran; water at 22℃; for 18h; Inert atmosphere;14%
everolimus
159351-69-6

everolimus

40-O-(2-hydroxy)ethyl rapamycin

40-O-(2-hydroxy)ethyl rapamycin

Conditions
ConditionsYield
With triethylammonium acetate In 1,4-dioxane; water at 22 - 28℃; for 4h;
1H-benzo[d][1,2,3]triazol-1-yl (2-(pyridin-2-yldisulfaneyl)ethyl) carbonate
913168-10-2

1H-benzo[d][1,2,3]triazol-1-yl (2-(pyridin-2-yldisulfaneyl)ethyl) carbonate

everolimus
159351-69-6

everolimus

everolimus (2'-pyridyldisulfanyl)ethyl carbonate
1312678-90-2

everolimus (2'-pyridyldisulfanyl)ethyl carbonate

Conditions
ConditionsYield
With dmap In dichloromethane for 0.5h; Inert atmosphere;
malonic acid
141-82-2

malonic acid

everolimus
159351-69-6

everolimus

C54H83NO15

C54H83NO15

Conditions
ConditionsYield
In methanol at 20℃; for 10h;

Everolimus Specification

The Everolimus is an organic compound with the formula C53H83NO14. With the CAS registry number 159351-69-6, it is also named as Certican. The product's categories are All Inhibitors; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals. Besides, it is an off white aolid, which should be stored at temperature of -20 °C. Everolimus is used in drug-eluting coronary stents as an immunosuppressant to prevent restenosis.

Physical properties about Everolimus are: (1)ACD/LogP: 3.35; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 3.35; (4)ACD/LogD (pH 7.4): 3.35; (5)#H bond acceptors: 15; (6)#H bond donors: 3; (7)#Freely Rotating Bonds: 12; (8)Polar Surface Area: 204.66 Å2; (9)Index of Refraction: 1.548; (10)Molar Refractivity: 257.69 cm3; (11)Molar Volume: 811.2 cm3; (12)Polarizability: 102.15×10-24cm3; (13)Surface Tension: 51.3 dyne/cm; (14)Density: 1.18 g/cm3; (15)Flash Point: 557.8 °C; (16)Enthalpy of Vaporization: 165.09 kJ/mol; (17)Boiling Point: 998.7 °C at 760 mmHg.

When you are using this chemical, please be cautious about it as the following:
This chemical is danger of serious damage to health by prolonged exposure if swallowed. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible).

You can still convert the following datas into molecular structure:
(1)SMILES: OCCO[C@@H]1CC[C@H](C[C@H]1OC)C[C@@H](C)[C@@H]4CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)[C@@H](OC)C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N3CCCC[C@H]3C(=O)O4
(2)InChI: InChI=1/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1
(3)InChIKey: HKVAMNSJSFKALM-GKUWKFKPBE
(4)Std. InChI: InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1
(5)Std. InChIKey: HKVAMNSJSFKALM-GKUWKFKPSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View